Skip to main content
Fig. 3 | Annals of Clinical Microbiology and Antimicrobials

Fig. 3

From: Safety and bactericidal efficacy of cold atmospheric plasma generated by a flexible surface Dielectric Barrier Discharge device against Pseudomonas aeruginosa in vitro and in vivo

Fig. 3

Viability of V79 fibroblasts after exposure to CAP. V79 fibroblasts in Matriderm® were exposed to CAP for 1–4 min and thereafter the metabolic activity per V79 fibroblast was determined. Results are expressed relative to the unexposed control samples. Data represent the means of at least three independent experiments performed in duplicate. Statistically significant differences were not detected (MWU; p > 0.05)

Back to article page